OrthoPediatrics, a pediatric orthopedics company, announced its interim financial highlights for the fourth quarter (4Q) 2024 and full year ended December 31, 2024.
Business and Financial Highlights:
- Generated record preliminary unaudited full year net revenue of $204.7 million, representing growth of 38 percent compared to $148.7 million in 2023. Preliminary full year domestic net revenue is expected to be $161.1 million, representing 45 percent annual growth; international net revenue is expected to be $43.6 million, representing 16 percent annual growth.
- Generated preliminary unaudited 4Q 2024 net revenue of $52.7 million, representing growth of 40 percent compared to $37.6 million in 4Q 2023. Preliminary domestic 4Q net revenue is expected to be $42.9 million, representing 52 percent growth compared to the prior year period, and international net revenue is expected to be $9.8 million, representing 5 percent growth compared to the prior year period.
2025 Financial Guidance:
OrthoPediatrics announced its projected 2025 revenue to be between $235 million and $242 million, representing 15 percent to 18 percent growth compared to full year 2024 preliminary unaudited net revenue. The company also expects its annual set deployment to be approximately $15 million and expects to generate between $15 million to $17 million of adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) for 2025.
“Throughout 2024 we continued to deliver strong results, advance our strategic initiatives, and grow our market share within pediatric orthopedics. Our trauma and deformity and scoliosis businesses continue to execute and contribute to our overall growth as we drove topline revenue and significantly increased profitability,” said David Bailey, president and CEO. “We are extremely pleased with the specialty bracing (OPSB) business performance. It has proven to be a tremendous market opportunity and provided an important strategic catalyst to further support our current customers. We are only beginning to scratch the surface of the potential for this business as a capital efficient top and bottom line driver we will continue to expand and scale over the coming years. As we look ahead, we are confident we have the right growth drivers in place to execute against our long-term outlook and deliver results all while we continue to make an impact for children.”
